Joint Meeting of the Peripheral and Central Nervous System Drugs
Advisory Committee (PCNS) and the Psychopharmacologic Drugs Advisory Committee
(PDAC)
July 10, 2008
SLIDES
FDA Presentations
Antiepileptic Drugs and Suicidality: Statistical Review, Mark
Levenson, Ph.D., Quantitative Safety and Pharmacoepidemiology Group Division of
Biometrics 6/CDER/FDA (ppt) (html)
Antiepileptic Drugs and Suicidality: Background, Evelyn Mentari,
M.D., M.S., Division of Neurology Products/CDER/FDA (ppt) (html)
Antiepileptic Drugs and Suicidality: Discussion, Evelyn Mentari,
M.D., M.S., Division of Neurology Products/CDER/FDA (ppt) (html)
Preliminary Statistical Comments on Pfizer Gabapentin and Pregabalin
Analysis, Mark Levenson, Ph.D., Quantitative Safety and Pharmacoepidemiology
Group Division of Biometrics 6/CDER/FDA (ppt)
(html)
Sponsor Presentation
Pfizer core
presentation and backup files (pdf)
Open Public Hearing
OPH 1 (pdf) (html)
OPH 2 (pdf) (html)
OPH 3 (pdf) (html)
OPH 4 (pdf) (html)
OPH 5 (pdf) (html)
Up
| AC Home Page